TY - JOUR
T1 - Impacto de la pandemia por covid-19 sobre el trasplante hepático en la argentina. Otro daño colateral
AU - Gondolesi, Gabriel E.
AU - Reyes-Toso, María Laura
AU - Bisigniano, Liliana
AU - De Santibañes, Martín
AU - Pekolj, Juan
AU - Maurette, Rafael
AU - Quiñonez, Emilio G.
AU - Maraschio, Martín A.
AU - Imventarza, Oscar
AU - Lendoire, Javier
AU - Bitetti, Lisandro
AU - Ruf, Andrés
AU - Aballay, Gabriel
AU - Gil, Octavio
AU - Mattera, Francisco J.
AU - Schelotto, Pablo Barros
AU - Descalzi, Valeria I.
N1 - Publisher Copyright:
© 2020, Instituto de Investigaciones Medicas. All rights reserved.
PY - 2020
Y1 - 2020
N2 - The COVID-19 pandemic declared in March 2020, has generated worldwide concern due to its effect on the health of the population and the potential health collapse. The strategy of “flattening the curve” through social distancing made it possible to adapt the resources of the health system to patients with COVID-19, but results in other areas of health could not be predicted. The objective of this work was to analyze the consequences of the pandemic on liver transplantation in general and for hepatocarcinoma (HCC). The following studies were carried out: a) a retrospective analysis using data from the CRESI / INCUCAI to compare admission to the waiting list, mortality on the list, donation and liver transplantation from 03/20 to 08/15, 2019 and the same period in 2020, and b) a survey of the transplant centers with the highest transplant activity to assess the effect of the measures taken in different institutional and regional situations. The first analysis showed a 55% decrease in liver transplants, with a similar reduction in donation and admission to the liver waiting list; while HCC transplantation rose from 10% in 2019 to 22% in 2020. The second analysis showed that the occupancy rate of beds by COVID-19 patients / week was variable: from 0.4% to 42.0%. The number of surgeries, hepato-bilio-pancreatic, resection of HCC and liver transplantation, were reduced by 47%, 49%, 31% and 36% respectively. The reduction in transplant activity mainly affected centers with high occupancy due to COVID-19. The final long-term outcome will need to be assessed.
AB - The COVID-19 pandemic declared in March 2020, has generated worldwide concern due to its effect on the health of the population and the potential health collapse. The strategy of “flattening the curve” through social distancing made it possible to adapt the resources of the health system to patients with COVID-19, but results in other areas of health could not be predicted. The objective of this work was to analyze the consequences of the pandemic on liver transplantation in general and for hepatocarcinoma (HCC). The following studies were carried out: a) a retrospective analysis using data from the CRESI / INCUCAI to compare admission to the waiting list, mortality on the list, donation and liver transplantation from 03/20 to 08/15, 2019 and the same period in 2020, and b) a survey of the transplant centers with the highest transplant activity to assess the effect of the measures taken in different institutional and regional situations. The first analysis showed a 55% decrease in liver transplants, with a similar reduction in donation and admission to the liver waiting list; while HCC transplantation rose from 10% in 2019 to 22% in 2020. The second analysis showed that the occupancy rate of beds by COVID-19 patients / week was variable: from 0.4% to 42.0%. The number of surgeries, hepato-bilio-pancreatic, resection of HCC and liver transplantation, were reduced by 47%, 49%, 31% and 36% respectively. The reduction in transplant activity mainly affected centers with high occupancy due to COVID-19. The final long-term outcome will need to be assessed.
KW - COVID-19
KW - Collateral damage
KW - Hepatocarcinoma
KW - Liver transplantation
UR - http://www.scopus.com/inward/record.url?scp=85100326936&partnerID=8YFLogxK
M3 - Article
C2 - 33481736
AN - SCOPUS:85100326936
SN - 0025-7680
VL - 80
SP - 71
EP - 82
JO - Medicina
JF - Medicina
ER -